23:34:42Canada

IMMUTEP Ltd (PRRUF)

OTC Markets

Key stats Fiscal year 2025

Income statement

Revenue
10,331,373 31.8%
Net income
-61,434,165
Earnings per share
-0.04
R&D expense
49,778,916

Growth and profitability

Net margin
-594.64
Return on equity
-42.77
Return on assets
-39.13
Free cash flow margin
-601.04

Balance sheet

Total assets
156,983,434
Total liabilities
13,348,071
Shareholders' equity
143,635,363
Cash and equivalents
67,408,215
Current ratio
11.69

Cash flow and ratios

Operating cash flow
-62,049,706
Free cash flow
-62,095,475

Shareholder returns

Shares outstanding
1,473,721,306
Book value per share
0.10
Revenue and net income
From revenue to profit 2025
Debt, free cash flow and cash
Earnings per share

Company information

Headquarters
Sydney,, C3
Exchange
OTC Markets
Fiscal year end
06-30
Industry (SEC)
Pharmaceutical Preparations

Fiscal year end: · Source: SEC EDGAR

IMMUTEP Ltd trades on OTC Markets under the ticker symbol PRRUF. This page brings together its price chart, company profile, key financial figures and technical indicators.

Company profile

Technical analysis